No connection

Search Results

SBCWW

BEARISH
$0.22 Live
SBC Medical Group Holdings Incorporated · NASDAQ
$0.22 52W Range $0.24
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Ownership

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 19, 2026
Market cap
N/A
P/E
N/A
ROE
22.3%
Profit margin
29.4%
Debt/Equity
0.2
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
75%
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating fundamental trends. While the company exhibits strong profitability margins and a very low Price-to-Book ratio (0.09), these are offset by negative revenue growth (-10.90%) and a completely bearish technical trend. The lack of an Altman Z-Score and Graham Number, combined with the asset's likely nature as a warrant (SBCWW), suggests high speculative risk. Overall, the disconnect between high margins and shrinking top-line growth suggests unsustainable efficiency or non-operational gains.

Key Strengths

High Gross Margin (73.32%)
Strong Operating Margin (32.47%)
Low Debt-to-Equity ratio (0.20)
Robust liquidity with a Current Ratio of 3.78
Strong Return on Equity (22.27%)

Key Risks

Weak Piotroski F-Score (3/9) indicating poor financial health trends
Negative Year-over-Year revenue growth (-10.90%)
Severe bearish technical trend (0/100)
Lack of institutional ownership and analyst coverage
High price volatility and consistent long-term price decline (-19.1%)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
30
Weak
Value
60
Future
40
Past
20
Health
30
Dividend
0
AI Verdict
Speculative/High Risk
Key drivers: Piotroski F-Score weakness, Negative revenue growth, Bearish technicals, Extreme P/B discount
Confidence
80%
Value
60/100

Trades at a massive discount to book value, but lacks earnings-based valuation metrics.

Positives
  • Price-to-Book ratio of 0.09 is extremely low
Watchpoints
  • No P/E or Graham Number available for traditional valuation
Future
40/100

Earnings growth is decoupled from revenue growth, suggesting cost-cutting rather than expansion.

Positives
  • Significant earnings growth (117.50%)
Watchpoints
  • Declining revenue growth (-10.90%)
Past
20/100

Long-term price performance is consistently negative.

Positives
No standout positives identified.
Watchpoints
  • Consistent -19.1% decline across 1Y, 3Y, and 5Y timeframes
Health
30/100

Strong balance sheet ratios are contradicted by the weak Piotroski trend score.

Positives
  • Low debt/equity
  • High current ratio
Watchpoints
  • Piotroski F-Score of 3/9
Dividend
0/100

Dividend strength is 0/100.

Positives
No standout positives identified.
Watchpoints
  • No dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.22

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for SBCWW and closest competitors.

Updated 2026-04-17
SBC
SBC Medical Group Holdings Incorporated
Primary
5Y
-19.1%
3Y
-19.1%
1Y
-19.1%
6M
-19.1%
1M
0.0%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.09
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin 29.37%
Operating Margin 32.47%
Gross Margin 73.32%
ROE 22.27%
ROA 13.05%

Growth

Revenue and earnings growth rates

Revenue Growth -10.9%
Earnings Growth +117.5%
Q/Q Revenue Growth -10.93%
Q/Q Earnings Growth +117.2%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.2
Low debt
Current Ratio
3.78
Strong
Quick Ratio
3.56
Excellent
Cash/Share
$1.6

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
73.1%
Op. Margin
32.5%
Net Margin
35.9%
Total Assets
$0.4B
Liabilities
$0.1B
Equity
$0.2B
Debt/Equity
0.47x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
98%

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Decagon Asset Management LLP
1,181,391 shares • 2025-12-31
Polar Asset Management Partners Inc.
685,700 shares • 2025-12-31
Aristeia Capital, LLC
529,961 shares • 2025-12-31
MMCAP International, Inc. SPC
330,000 shares • 2025-12-31
Weiss Asset Management Lp
229,192 shares • 2025-12-31
Context Capital Management, LLC
208,389 shares • 2025-12-31
Yakira Capital Management, Inc.
208,303 shares • 2025-12-31
Saba Capital Management, L.P.
200,000 shares • 2025-12-31

Past News Coverage

Recent headlines mentioning SBCWW from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile